VIA
WST icon

Vident Investment Advisory’s West Pharmaceutical WST Stock Holding History

Vident Investment Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,303
Closed -$498K – 1088
2023
Q2 		$498K Sell
1,303
-453
-26% -$162K 0.02% 699
2023
Q1 		$608K Buy
1,756
+351
+25% +$103K 0.02% 702
2022
Q4 		$331K Buy
+1,405
New +$333K 0.01% 853
2022
Q3 		– Sell
-883
Closed -$271K – 1349
2022
Q2 		$271K Sell
883
-1,055
-54% -$343K 0.01% 1051
2022
Q1 		$795K Sell
1,938
-1,620
-46% -$634K 0.02% 785
2021
Q4 		$1.67M Sell
3,558
-416
-10% -$179K 0.04% 529
2021
Q3 		$1.69M Sell
3,974
-2,188
-36% -$922K 0.05% 507
2021
Q2 		$2.21M Buy
6,162
+2,231
+57% +$737K 0.07% 367
2021
Q1 		$1.11M Buy
3,931
+1,162
+42% +$333K 0.04% 586
2020
Q4 		$784K Buy
2,769
+40
+1% +$11.2K 0.03% 599
2020
Q3 		$750K Sell
2,729
-626
-19% -$166K 0.04% 569
2020
Q2 		$762K Buy
3,355
+430
+15% +$84.5K 0.04% 552
2020
Q1 		$445K Buy
+2,925
New +$450K 0.03% 599
2015
Q3 		– Sell
-11,194
Closed -$650K – 1160
2015
Q2 		$650K Buy
11,194
+411
+4% +$22.9K 0.09% 333
2015
Q1 		$649K Sell
10,783
-1,550
-13% -$82.6K 0.13% 243
2014
Q4 		$657K Buy
+12,333
New +$617K 0.22% 136

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vident Investment Advisory's WST Position: Q3 2023 in Review

Vident Investment Advisory sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 1,303 shares — an estimated $498K sold.

Vident Investment Advisory first reported a position in WST in Q4 2014 and held it in 16 quarters. The position peaked at $2.21M in Q2 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Vident Investment Advisory reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 1,303 West Pharmaceutical shares in Q3 2023, an estimated $498K.
  • Vident Investment Advisory first reported a position in West Pharmaceutical in Q4 2014 and held it in 16 quarters.
  • Vident Investment Advisory's West Pharmaceutical position peaked at $2.21M in Q2 2021.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.